Michael Gould to Neoplasm Staging
This is a "connection" page, showing publications Michael Gould has written about Neoplasm Staging.
Connection Strength
3.080
-
The five commandments of efficient and effective care in the initial evaluation of lung cancer. Curr Opin Pulm Med. 2016 07; 22(4):319-26.
Score: 0.502
-
Multidisciplinary management of lung cancer. N Engl J Med. 2004 May 06; 350(19):2008-10; author reply 2008-10.
Score: 0.216
-
Test performance of positron emission tomography and computed tomography for mediastinal staging in patients with non-small-cell lung cancer: a meta-analysis. Ann Intern Med. 2003 Dec 02; 139(11):879-92.
Score: 0.210
-
Methods for the Watch the Spot Trial. A Pragmatic Trial of More- versus Less-Intensive Strategies for Active Surveillance of Small Pulmonary Nodules. Ann Am Thorac Soc. 2019 12; 16(12):1567-1576.
Score: 0.159
-
Comorbidity Profiles and Their Effect on Treatment Selection and Survival among Patients with Lung Cancer. Ann Am Thorac Soc. 2017 Oct; 14(10):1571-1580.
Score: 0.137
-
Invasive Mediastinal Staging in Lung Cancer. Use a Prediction Model or Just Do It? Am J Respir Crit Care Med. 2017 06 15; 195(12):1556-1558.
Score: 0.134
-
Anxiety, Culture, and Expectations: Oncologist-Perceived Factors Associated With Use of Nonrecommended Serum Tumor Marker Tests for Surveillance of Early-Stage Breast Cancer. J Oncol Pract. 2017 01; 13(1):e77-e90.
Score: 0.129
-
Surveillance Imaging in Patients with Resected Non-Small Cell Lung Cancer: Too Much, Not Enough, or Just Right? Ann Am Thorac Soc. 2016 09; 13(9):1446-7.
Score: 0.127
-
Brain Imaging for Staging of Patients With Clinical Stage IA Non-small Cell Lung Cancer in the National Lung Screening Trial: Adherence With Recommendations From the Choosing Wisely Campaign. Chest. 2016 Apr; 149(4):943-50.
Score: 0.122
-
Use of posttreatment imaging and biomarkers in survivors of early-stage breast cancer: Inappropriate surveillance or necessary care? Cancer. 2016 Mar 15; 122(6):908-16.
Score: 0.121
-
Use of imaging for staging of early-stage breast cancer in two integrated health care systems: adherence with a choosing wisely recommendation. J Oncol Pract. 2015 May; 11(3):e320-8.
Score: 0.116
-
Facility-level analysis of PET scanning for staging among US veterans with non-small cell lung cancer. Chest. 2014 Apr; 145(4):839-847.
Score: 0.107
-
Methods for staging non-small cell lung cancer: Diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines. Chest. 2013 May; 143(5 Suppl):e211S-e250S.
Score: 0.101
-
Automated identification of patients with pulmonary nodules in an integrated health system using administrative health plan data, radiology reports, and natural language processing. J Thorac Oncol. 2012 Aug; 7(8):1257-62.
Score: 0.096
-
The use and misuse of positron emission tomography in lung cancer evaluation. Clin Chest Med. 2011 Dec; 32(4):749-62.
Score: 0.091
-
Disparities in lung cancer staging with positron emission tomography in the Cancer Care Outcomes Research and Surveillance (CanCORS) study. J Thorac Oncol. 2011 May; 6(5):875-83.
Score: 0.088
-
Positron emission tomography 18F-fluorodeoxyglucose uptake and prognosis in patients with surgically treated, stage I non-small cell lung cancer: a systematic review. J Thorac Oncol. 2009 Dec; 4(12):1473-9.
Score: 0.080
-
Timeliness across the continuum of care in veterans with lung cancer. J Thorac Oncol. 2008 Sep; 3(9):951-7.
Score: 0.073
-
Timeliness of care in veterans with non-small cell lung cancer. Chest. 2008 May; 133(5):1167-73.
Score: 0.070
-
A clinical prediction rule to estimate the probability of mediastinal metastasis in patients with non-small cell lung cancer. J Thorac Oncol. 2006 Nov; 1(9):953-9.
Score: 0.064
-
Accuracy of transbronchial needle aspiration for mediastinal staging of non-small cell lung cancer: a meta-analysis. Thorax. 2005 Nov; 60(11):949-55.
Score: 0.059
-
The benefits and harms of adjuvant chemotherapy for non-small cell lung cancer in patients with major comorbidities: A simulation study. PLoS One. 2022; 17(11):e0263911.
Score: 0.049
-
Management of Lung Nodules and Lung Cancer Screening During the COVID-19 Pandemic: CHEST Expert Panel Report. Chest. 2020 07; 158(1):406-415.
Score: 0.041
-
Strategy and cost in investigating solitary pulmonary nodules. Thorax. 1998 Aug; 53 Suppl 2:S32-7.
Score: 0.036
-
Lung cancer. Curr Opin Pulm Med. 1997 Jul; 3(4):243-6.
Score: 0.034
-
Patients' Knowledge, Beliefs, and Distress Associated with Detection and Evaluation of Incidental Pulmonary Nodules for Cancer: Results from a Multicenter Survey. J Thorac Oncol. 2016 05; 11(5):700-708.
Score: 0.031
-
Lung cancer stage at diagnosis: Individual associations in the prospective VITamins and lifestyle (VITAL) cohort. BMC Cancer. 2011 Jun 07; 11:228.
Score: 0.022
-
An official American Thoracic Society systematic review: insurance status and disparities in lung cancer practices and outcomes. Am J Respir Crit Care Med. 2010 Nov 01; 182(9):1195-205.
Score: 0.021
-
PET scan 18F-fluorodeoxyglucose uptake and prognosis in patients with resected clinical stage IA non-small cell lung cancer. Chest. 2010 May; 137(5):1150-6.
Score: 0.020
-
Noninvasive staging of non-small cell lung cancer: ACCP evidenced-based clinical practice guidelines (2nd edition). Chest. 2007 Sep; 132(3 Suppl):178S-201S.
Score: 0.017
-
Usefulness of positron emission tomography imaging in the management of lung cancer. Curr Opin Pulm Med. 1999 Jul; 5(4):201-7.
Score: 0.010